Dataset Information

PRM-MS quantitative analysis of isomeric N-glycopeptides derived from human serum haptoglobin of patients with cirrhosis and hepatocellular carcinoma

ABSTRACT: Comprehensive LC-PRM-MS approach where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system to study the microheterogeneity of serum haptoglobin (Hp) extracted from 15 patients with cirrhosis and 15 with hepatocellular carcinoma (HCC).

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Non-alcoholic Steatohepatitis,Liver Cancer,Liver Cirrhosis

SUBMITTER: Cristian Gutierrez Reyes

LAB HEAD: Dr. Yehia Mechref

PROVIDER: PXD023719 | Pride | 2021-09-10

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	GlycoPeptide_50cmC18_TGHPT_NASH58_PRM.raw	Raw
	GlycoPeptide_50cmC18_TGHPT_NASH60_PRM.raw	Raw
	GlycoPeptide_50cmC18_TGHPT_NASH61_PRM.raw	Raw
	GlycoPeptide_50cmC18_TGHPT_NASH62_PRM.raw	Raw
	GlycoPeptide_50cmC18_TGHPT_NASH63_PRM.raw	Raw

Items per page:

1 - 5 of 64

Publications

PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma.

Gutierrez Reyes Cristian D CD Huang Yifan Y Atashi Mojgan M Zhang Jie J Zhu Jianhui J Liu Suyu S Parikh Neehar D ND Singal Amit G AG Dai Jianliang J Lubman David M DM Mechref Yehia Y

Metabolites 20210823 8

Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography-parallel reaction monitoring-mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study t ...[more]

PMID: 34436504

Similar Datasets

Project description:Recombinant proteins are of great interest in glycobiology and proteomics, known especially for their reproducibility and accessibility. However, variation in glycosylation among recombinant glycoproteins is not well understood and may depend on numerous conditions in the biomanufacturing process. In order to confidently assess variation in glycosylation measurements, it is vital to both optimize the measurement of, and determine the degree of variation between, distributions of glycosylation on specific sites of glycoproteins. This is especially important for glycoproteins that are known to have rapid sequence changes, such as with different influenza strains. In this study, eight strains of recombinant influenza hemagglutinin and neuraminidase produced from HEK293 cell line were obtained from four vendors and digestion was conducted using a series of complex multi-enzymatic methods designed to isolate glycopeptide sequons. Site-specific glycosylation profiles of intact glycopeptides were produced using mass spectrometric evaluation on an orbitrap system and compared using spectral similarity scores. Variation in glycan abundances and distribution was most pronounced between different strains of virus (similarity score = 383 out of 1000), whereas replicates resulted in low variation (similarity score = 957 out of 1000). Glycan variation was also measured based on differences between vendors, lots, batches, protease digestion, and intra-protein site. The most abundant glycans in all of these influenza glycoproteins were monofucosylated and complex, as reported by other laboratories. However, it was found that different vendors can produce very different glycan distributions for the same glycosylation site. Notably, it is demonstrated that glycan distributions are similar for conserved regions of influenza glycoproteins. Overall, these methods present a potential use in developing reproducible measurements of glycosylated biologics for quality control or making more informed decisions in biomanufacturing.